\
&
Contact us
This was 9 months ago
LocationOnline
ProgrammesThe COST Association will organize an online COST info session on 18 February 2025 from 10h00-11h45. The aim of this event is to inform researchers and innovators about how to connect with COST Actions or submit a COST Action proposal, the role and impact of the COST programme, and the benefits of participating in COST for researchers’ careers, with a focus on young researchers.
More information on this event and agenda can be found here
The next collection date for COST proposals will be 21 October 2025 at 12.00 (noon) CEST. More information can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.